StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.00+0.09 (+3.09%)

Close on Nov 17, 2026Market cap $11.85MP/E –Yield –

Onconetix price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Onconetix's price to sales ratio was 22.1× on Nov 11, 2026, against 17.0× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202622.1×−377.8
2025Jul 31, 2025399.8×–

More Onconetix figures

See a number that looks wrong?